In stage 1B, the tumor hasn’t reached the lymph ... There are at least two nodules in different lobes of the same lung. The cancer may have spread to the lymph nodes in or near the lungs.

Roche's Alecensa has been recommended for routine NHS use as an adjuvant treatment for ALK-positive non-small cell lung cancer (NSCLC ... for patients with stage 1b to 3a ALK-positive NSCLC ...

Lung cancer typically is diagnosed at a later stage than other malignancies, due to the lack of early warning indications. In 2020 it was China’s most common cancer and the leading cause of ...

Low-dose CT screening in a high-risk population detected lung cancer in 2.0% of participants, with nearly 80% of cases diagnosed at stage I or II. The screening protocol demonstrated 97.0% ...

a pre-commercial-stage biopharmaceutical company ... or platinum-refractory extensive small cell lung cancer. “We are encouraged by the Phase 1b trial data which suggests preliminary anti ...

Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial responders. All participants with disease control experienced a ...

Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial responders. All participants with disease control experienced ...